These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. Tuettenberg A, Huter E, Hubo M, Horn J, Knop J, Grimbacher B, Kroczek RA, Stoll S, Jonuleit H. J Immunol; 2009 Mar 15; 182(6):3349-56. PubMed ID: 19265111 [Abstract] [Full Text] [Related]
31. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine. Liu J, Ngai N, Stone GW, Yue FY, Ostrowski MA. Vaccine; 2009 Aug 13; 27(37):5077-84. PubMed ID: 19573639 [Abstract] [Full Text] [Related]
35. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. Serghides L, Bukczynski J, Wen T, Wang C, Routy JP, Boulassel MR, Sekaly RP, Ostrowski M, Bernard NF, Watts TH. J Immunol; 2005 Nov 15; 175(10):6368-77. PubMed ID: 16272289 [Abstract] [Full Text] [Related]
38. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion. Eljaafari A, Li YP, Miossec P. J Immunol; 2009 Sep 01; 183(5):2932-45. PubMed ID: 19696431 [Abstract] [Full Text] [Related]
40. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy. Shibahara I, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T. Mol Cancer; 2015 Feb 15; 14():41. PubMed ID: 25744203 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]